194 related articles for article (PubMed ID: 15145150)
21. [Cancer of the prostate: results of radiotherapy. Multicenter study].
Allain YM; Bolla M; Douchez J; Gary-Bobo J; Geslin J; Huart J; Mathieu G; Mazeron JJ
Bull Cancer; 1985; 72(6):559-67. PubMed ID: 3912017
[TBL] [Abstract][Full Text] [Related]
22. [Prostate-specific antigen as an evaluation method in the treatment of hormone-refractory cancer of the prostate].
Morote J; Lorente JA; Vallejo C; Encabo G; López-Pacios MA; De Torres JA; Soler Rosello A
Actas Urol Esp; 1994 Jun; 18(6):656-9. PubMed ID: 7524278
[TBL] [Abstract][Full Text] [Related]
23. Local control of prostate cancer with radiotherapy: frequency and prognostic significance of positive results of postirradiation prostate biopsy.
Scardino PT; Wheeler TM
NCI Monogr; 1988; (7):95-103. PubMed ID: 3050543
[TBL] [Abstract][Full Text] [Related]
24. Prostate-specific antigen as a predictor of radiotherapy response and patterns of failure in localized prostate cancer.
Ritter MA; Messing EM; Shanahan TG; Potts S; Chappell RJ; Kinsella TJ
J Clin Oncol; 1992 Aug; 10(8):1208-17. PubMed ID: 1378886
[TBL] [Abstract][Full Text] [Related]
25. Radiation therapy for localized prostate carcinoma: experience at the Massachusetts General Hospital (1973-1981).
Shipley WU; Prout GR; Coachman NM; McManus PL; Healey EA; Althausen AF; Heney NM; Parkhurst EC; Young HH; Shipley JW
NCI Monogr; 1988; (7):67-73. PubMed ID: 3173505
[TBL] [Abstract][Full Text] [Related]
26. Relationship of tumor DNA-ploidy to serum prostate-specific antigen doubling time after radiotherapy for prostate cancer.
Pollack A; Zagars GK; el-Naggar AK; Terry NH
Urology; 1994 Nov; 44(5):711-8. PubMed ID: 7526527
[TBL] [Abstract][Full Text] [Related]
27. [Conformation radiotherapy of carcinoma of the prostate].
Shimizu T; Tanaka Y; Takeshita N; Matsuda T
Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Jul; 52(7):993-1000. PubMed ID: 1508659
[TBL] [Abstract][Full Text] [Related]
28. Prostate specific antigen density is not an independent predictor of response for prostate cancer treated by conformal radiotherapy.
Corn BW; Hanks GE; Lee WR; Bonin SR; Hudes G; Schultheiss T
J Urol; 1995 Jun; 153(6):1855-9. PubMed ID: 7538598
[TBL] [Abstract][Full Text] [Related]
29. Prostatic cancer treated by external irradiation at the Rotterdam Radiotherapy Institute.
van der Werf-Messing BH; Menon RS; van Putten WL
Strahlentherapie; 1984 May; 160(5):293-300. PubMed ID: 6729864
[TBL] [Abstract][Full Text] [Related]
30. Prostate-specific antigen. Monitoring the response of carcinoma of the prostate to radiotherapy with a new tumor marker.
Dundas GS; Porter AT; Venner PM
Cancer; 1990 Jul; 66(1):45-8. PubMed ID: 1693877
[TBL] [Abstract][Full Text] [Related]
31. [Clinical studies on endocrine therapy for prostatic carcinoma (5): Analyses of relapse from endocrine therapy].
Kumamoto Y; Tsukamoto T; Umehara T; Shimazaki J; Fuse H; Ohshima H; Takeuchi H; Yoshida O; Okada K; Saito Y
Hinyokika Kiyo; 1991 Nov; 37(11):1511-8. PubMed ID: 1767774
[TBL] [Abstract][Full Text] [Related]
32. The national Canadian study of carcinoma of the prostate treated by external beam radiation (1970-1978): I. a medical audit.
McGowan DG; Hanson J
J Can Assoc Radiol; 1985 Sep; 36(3):216-22. PubMed ID: 3840170
[TBL] [Abstract][Full Text] [Related]
33. Prostate specific antigen in the management of patients with localized adenocarcinoma of the prostate treated with primary radiation therapy.
Russell KJ; Dunatov C; Hafermann MD; Griffeth JT; Polissar L; Pelton J; Cole SB; Taylor EW; Wiens LW; Koh WJ
J Urol; 1991 Oct; 146(4):1046-52. PubMed ID: 1716696
[TBL] [Abstract][Full Text] [Related]
34. The T classification of clinically localized prostate cancer. An appraisal based on disease outcome after radiation therapy.
Zagars GK; Geara FB; Pollack A; von Eschenbach AC
Cancer; 1994 Apr; 73(7):1904-12. PubMed ID: 7511040
[TBL] [Abstract][Full Text] [Related]
35. Prostate specific antigen doubling time and disease relapse after radiotherapy for prostate cancer.
Pollack A; Zagars GK; Kavadi VS
Cancer; 1994 Jul; 74(2):670-8. PubMed ID: 7518341
[TBL] [Abstract][Full Text] [Related]
36. Early prostate cancer: the national results of radiation treatment from the Patterns of Care and Radiation Therapy Oncology Group studies with prospects for improvement with conformal radiation and adjuvant androgen deprivation.
Hanks GE; Hanlon A; Schultheiss T; Corn B; Shipley WU; Lee WR
J Urol; 1994 Nov; 152(5 Pt 2):1775-80. PubMed ID: 7523724
[TBL] [Abstract][Full Text] [Related]
37. Use of human prostate-specific antigen in monitoring prostate cancer.
Kuriyama M; Wang MC; Lee CI; Papsidero LD; Killian CS; Inaji H; Slack NH; Nishiura T; Murphy GP; Chu TM
Cancer Res; 1981 Oct; 41(10):3874-6. PubMed ID: 7284995
[TBL] [Abstract][Full Text] [Related]
38. Serum PSA as a tumor marker for patients undergoing definitive radiation therapy.
Zagars GK
Urol Clin North Am; 1993 Nov; 20(4):737-47. PubMed ID: 7505982
[TBL] [Abstract][Full Text] [Related]
39. Influence of initial presentation on treatment outcome of clinically localized prostate cancer treated by definitive radiation therapy.
Geara FB; Zagars GK; Pollack A
Int J Radiat Oncol Biol Phys; 1994 Sep; 30(2):331-7. PubMed ID: 7523344
[TBL] [Abstract][Full Text] [Related]
40. Prostate cancer.
Schlegel PN
Curr Ther Endocrinol Metab; 1994; 5():543-50. PubMed ID: 7535663
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
